Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure

Renal Insufficiency Clinical Trial

— EARLI  

Official title:

Impact of EArly Renal Involvement on the Developement of Severe In-hospital Renal Failure

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00806039
• Other study ID #: 1143004
• Status: Active, not recruiting
• Phase: N/A
• First received: December 9, 2008
• Last updated: July 14, 2009
• Start date: December 2008
• Est. completion date: July 2009

Study information

• Verified date: July 2009
• Source: Saint Louis VA Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether renal team involvement early at the onset of kidney injury will prevent further developement of more severe renal failure and worse hospitalization outcomes.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 300
• Est. completion date: July 2009
• Est. primary completion date: July 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Hospitalized, elevation in creatinine meeting definition

Exclusion Criteria:

• CDK5, ESRD,solid organ transplant

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Acute Kidney Injury
• Kidney Failure
• Kidney Failure, Acute
• Renal Insufficiency
• Renal Insufficiency, Acute

Intervention

Other:
• Early Renal Involvement
Renal Consultation

Locations

Country	Name	City	State
United States	Saint Louis VA Medical Center	Saint Louis	Missouri

Sponsors (1)

Lead Sponsor	Collaborator
Saint Louis VA Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Severe renal Failure		10 days	No
Secondary	Composite outcome morbidity mortality		hospitalization	No